EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Comparative Efficacy and Safety of Oral versus Intravenous Acetaminophen in Preterm Neonates with Patent Ductus Arteriosus: A Randomized Controlled Trial

Mostafa Behjati, Seyed Reza Mirjalili, Atefeh Sadeghi Panah, Mahmood Noorishadkam, Mohamad Hosein Lookzadeh, Farimah Shamsi

Pakistan Heart Journal · 01.05.2026 · 59 (2) · 256-262

DOI: 10.47144/phj.v59i2.2962 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pakistan Heart Journal, online erschienen am 01.05.2026. Verfasst von Mostafa Behjati und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to compare the efficacy and safety of oral versus intravenous acetaminophen in achieving ductal closure among preterm neonates with hemodynamically significant PDA. Methodology: In this randomized, double-blind controlled trial, 60 preterm neonates with echocardiographically confirmed PDA were randomly assigned to receive either oral acetaminophen (n=30) or intravenous acetaminophen (n=30), at a dosage of 15 mg/kg every 6 hours for 3 days. A second treatment course was given if PDA persisted. The primary outcome was ductal closure rate; secondary outcomes included adverse events, clinical symptoms, and echocardiographic parameters.

Results

After the first treatment course, closure occurred in 86.7% of the oral group and 90% of the intravenous group (p=0.500). Following a second course, all infants in both groups achieved complete closure. No significant differences were observed in ductal diameter reduction, time to closure, or hospital stay between groups (p>0.05). Adverse effects were infrequent (10% oral vs. 6.7% IV; p=0.500), and no severe complications were reported.

Conclusion

Oral acetaminophen was found to be equivalent to intravenous acetaminophen in achieving PDA closure, with comparable safety profiles. Given its cost-effectiveness and accessibility, oral acetaminophen may represent a viable first-line alternative for managing PDA in premature neonates.

Zitieren

APA

Behjati, M., Mirjalili, S. R., Panah, A. S., Noorishadkam, M., Lookzadeh, M. H., & Shamsi, F. (2026). Comparative Efficacy and Safety of Oral versus Intravenous Acetaminophen in Preterm Neonates with Patent Ductus Arteriosus: A Randomized Controlled Trial. Pakistan Heart Journal, 59(2), 256-262. https://doi.org/10.47144/phj.v59i2.2962

Vancouver

Behjati M, Mirjalili SR, Panah AS, Noorishadkam M, Lookzadeh MH, Shamsi F. Comparative Efficacy and Safety of Oral versus Intravenous Acetaminophen in Preterm Neonates with Patent Ductus Arteriosus: A Randomized Controlled Trial. Pakistan Heart Journal. 2026;59(2):256-262. doi:10.47144/phj.v59i2.2962

BibTeX
@article{Behjati2026,
  author = {Behjati, Mostafa and Mirjalili, Seyed Reza and Panah, Atefeh Sadeghi and Noorishadkam, Mahmood and Lookzadeh, Mohamad Hosein and Shamsi, Farimah},
  title = {Comparative Efficacy and Safety of Oral versus Intravenous Acetaminophen in Preterm Neonates with Patent Ductus Arteriosus: A Randomized Controlled Trial},
  journal = {Pakistan Heart Journal},
  year = {2026},
  volume = {59},
  number = {2},
  pages = {256--262},
  doi = {10.47144/phj.v59i2.2962}
}
Kostenlos starten →